Description: This webcast will oversee a discussion on the impact of LDTI (transitions and earnings), in addition to day two items and other considerations. Examples include pricing, reinsurance and non-GAAP adjustments.

Description: After the arduous journeys IFRS 17 filers underwent to implement the standard, it would only make sense for insurers to seek the best return on their investment post effective date of 1/1/2023. Many insurers are now embarking a new phase of the journey that involves wrapping up any unfinished business as they might have taken a minimum compliance route to finish implementation and thinking about the knock-on effects the new standard has on the way they carry out business and perform financial reporting.

Description: The session is based on an article of the same name featured in the January, 2023 issue of Health Watch. It gives a step-by-step method of how to apply the average paid PMPM method to calculate IBNR with zero run-out, as opposed to current methods, which generally require a three-month run-out period. Methods for obtaining confidence intervals for the IBNR estimates will also be discussed.

Description: Explore the role of inflation across health products, including medical plans, disability, and long-term care. Explore various drivers of cost trends, wage increase, and cost of care. Understand their role in the pricing and valuation of a product and how to manage the risk.

Description: Over the past year, the life industry has seen the continued expansion of the Registered Index Linked Annuity (RILA) market. In this session we will take a deep dive into registered index linked products. We will explore common product features and mechanics, key risks, pricing, regulatory, and reserving considerations, and reasons why RILAs have been successful. We will also consider the potential impacts of the rising interest rate environment on product sales and design.

Description: Appointed actuaries are facing a number of changes in the regulatory landscape. Some of these occurred in the past few years, such as AG51 (Asset Adequacy Testing for LTC). Some were very recently put in effect and are evolving, such as AG53 (Modeling and Documentation of Complex Assets). Some are quickly approaching, such as the potential changes to asset adequacy testing requirements for reinsurance ceded by life insurers. In addition, changes to qualification requirements are on the horizon. Hear from appointed actuaries about the challenges they’ve experienced and how they’ve worked through them. Also, learn what challenges and opportunities they see in the near future and how they are preparing for coming changes.

Description: This webcast compares and contrasts four key regulatory capital regimes for life insurers around the world: Risk-Based Capital (RBC) in the United States, Life Insurer Capital Adequacy Test (LICAT) in Canada, Solvency II in the European Union and the Bermuda Insurance Solvency (BIS) Framework in Bermuda.

Description: At the conclusion of this session attendees will be familiar with the status of the NAIC's GOES project and have a better understanding of the scenario sets under consideration and how they can be tested to assess the potential impact to principle-based reserve and capital levels.

Description: The recent round of regulatory changes (LDTI, IFRS 17, PBR) has put a demand on actuarial organizations, and in particular, financial reporting functions unlike most have experienced in their careers. With adoption, where does this leave the financial reporting function going forward? What work is left to be done? How will the financial reporting function need to evolve under these accounting regimes? Come explore these topics and more through a moderated debate, inclusive of the following questions: - What are the biggest 'day 2' items that remain on your organization's 'to-do' list? - How are valuation actuaries equipped to navigate the newly available data, understand the results, and tell the underlying earnings story? - How do new regulatory requirements fit into current close calendar requirements? - What are the peripheral impacts from regulatory change (e.g., FP&A, product development) and how are your valuation actuaries involved in these processes?

Description: IFRS 17 will be effective as of 1 Jan 2023 and provide opportunities as well as challenges to both Direct Writers and Reinsurers across the insurance industry. If the new framework is not fully understood, an implementation can elevate the risk of problems in financial reporting, product development, investment management and more. The transition to IFRS provides an opportunity for companies to optimize the financial position of the enterprise by implementing mitigating strategies to reduce the risks and challenges that IFRS brings to the table.